Home

News

According to WHO’s latest World Malaria Report the malaria burden remained stable in 2021 despite the pandemic and threats such as drug resistance 

Holding the line against malaria in 2021 despite ongoing challenges

08 Dec 2022
News story
Midwife Amichia Solange & Angelica Konate outside their health centre in Cote d'Ivoire

Meta-analysis supported by MMV, WHO, WWARN with funding from BMGF contributes to the WHO recommendation of artemisinin-based combination therapy artemether-lumefantrine 

WHO gives ‘strong recommendation’ supporting use of antimalarial drug to treat pregnant women in the first trimester

28 Nov 2022
News story
Young father holding his baby and kissing him on the cheek

Inclusion in the latest version of the WHO Guidelines for malaria is a key step towards broader use of the medicine

Strong Recommendation for Pyronaridine-Artesunate in Revised WHO Malaria Treatment Guidelines

25 Nov 2022
Press release
Young Ugandan school children sitting at desks turning to look at the camera
  • Novartis and Medicines for Malaria Venture (MMV) announce decision to move to Phase 3 study for novel non-artemisinin combination to treat uncomplicated malaria
  • This novel combination also contains an optimized formulation of lumefantrine, which allows it to be given once daily versus the usual twice-daily administration
  • As the world faces emerging resistance to current malaria treatments, new medicines are needed to continue the fight toward elimination

Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria

23 Nov 2022
Press release
View all news